Profil
Brandi L.
Simpson is currently the President, Chief Executive Officer & Director at Navigen, Inc. Prior to her current position, she worked as a Senior Director-Investor Relations at NPS Pharmaceuticals, Inc.
Postes actifs de Brandi L. Simpson
| Sociétés | Poste | Début |
|---|---|---|
Navigen, Inc.
 Navigen, Inc. Pharmaceuticals: MajorHealth Technology Navigen, Inc. operates as a drug discovery and development company. The company was founded by Hunter Jackson and is headquartered in Salt Lake City, UT. | Directeur Général | 01/01/2014 |
Anciens postes connus de Brandi L. Simpson
| Sociétés | Poste | Fin |
|---|---|---|
| NPS PHARMACEUTICALS, INC. | Public Communications Contact | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
Navigen, Inc.
Navigen, Inc. Pharmaceuticals: MajorHealth Technology Navigen, Inc. operates as a drug discovery and development company. The company was founded by Hunter Jackson and is headquartered in Salt Lake City, UT. | Health Technology |
